{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Agbioscience","title":"355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience","html":"","width":"100%","height":180,"duration":1086,"description":"Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into:  \n\nFrom speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding \nCrops of focus for Inari right now and stresses they’re focused on to enable farmer success \nThe company’s recent venture capital raise, their value proposition and educating investors \nInari’s unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time) \nThe status of field trials and what commercialization will look like for Inari \nBiggest problems in-field to be solved through gene editing – from yield to resource efficiencies \nRegulatory hurdles and Claudia’s perspective on the acceptance of gene editing as a technology \nWhen will Inari technology be in customer fields? And what’s next? ","thumbnail_url":"https://img.transistorcdn.com/fNR6XzpB2Kp8cz0_UeZ53to0jw3tZsavgDDSar67UYQ/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yZWEy/YjI3YzlhYWEzMzdm/NWU0NDIxYmEyMGI2/MmZjZC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}